Petmed Express Inc. (PETS) intrinsic value & 10-year financials

Petmed Express Inc. (PETS) has a Graham intrinsic value of $0.01 per share. At $1.18 on Oct 17, 2026, the stock trades 11700% above that value. Over the last 10 fiscal years revenue shrank 3.6% a year to $179.0M, with an average return on invested capital of -19.7%.

Graham intrinsic value
$0.01
Share price (Oct 17, 2026)
$1.18
Price vs Graham value
11700% above
Market cap
$24.7M
Revenue (FY2026)
$179.0M
Revenue growth (10-yr CAGR)
-3.6%
ROIC (10-yr avg)
-19.7%
Free cash flow (FY2026)
-$33.0M

PETS 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2026 $179.0M -$57.3M -$2.74 -$33.0M -32.8% -304.3%
FY2025 $227.0M -$6.3M -$0.30 -$395.0K -0.7% -4.2%
FY2024 $274.1M -$7.5M -$0.37 -$194.0K -3.0% -26.3%
FY2023 $247.6M $233.0K $0.01 $22.5M -0.6% -3.6%
FY2022 $273.4M $21.1M $1.04 $16.7M 9.4% 14.1%
FY2021 $309.2M $30.6M $1.52 $37.6M 12.2% 21.6%
FY2020 $284.1M $25.9M $1.29 $36.5M 10.9% 17.9%
FY2019 $283.4M $37.7M $1.84 $44.5M 16.3% 28.3%
FY2018 $273.8M $37.3M $1.82 $36.7M 19.0% 34.6%
FY2017 $249.2M $23.8M $1.17 $36.6M 15.0% 25.2%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

PETMED EXPRESS INC is facing top-line stagnation, with revenue contracting over the decade.

PETMED EXPRESS INC returns on capital have been average, hovering around 10.5% ROIC over the decade.

PETMED EXPRESS INC has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, PETMED EXPRESS INC is modeled at -3.6% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.01 per share.

PETS stock: frequently asked questions

What is the intrinsic value of Petmed Express Inc. (PETS) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a -3.6% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, PETS's intrinsic value is about $0.01 per share.

Is PETS stock undervalued?

At $1.18 (close on Oct 17, 2026), PETS trades 11700% above its Graham value of $0.01. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has Petmed Express Inc. grown?

Revenue went from $249.2M in fiscal 2017 to $179.0M in fiscal 2026, a compound annual growth rate of -3.6%. Net income was -$57.3M in fiscal 2026.

Does Petmed Express Inc. generate free cash flow?

Petmed Express Inc. generated -$33.0M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2026. Free cash flow was positive in 7 of the last 10 reported years.

What is PETS's return on invested capital?

Average ROIC over the last 10 fiscal years was -19.7%, and average return on equity was 3.4%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this PETS data come from?

From Petmed Express Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Jun 2, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar retail-drug stores and proprietary stores stocks